The Global Alliance for TB Drug Development and Tibotec have joined forces to develop a potential first-in-class drug for both drug-susceptible and drug-resistant tuberculosis. In June ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback